Chemed (CHE) Operating Income (2009 - 2026)

Chemed's Operating Income history runs 18 years deep, the most recent figure standing at $84.6 million for Q1 2026.

• In Q1 2026, Operating Income fell 10.74% year-over-year to $84.6 million; the TTM figure through Mar 2026 stood at $328.1 million (down 15.65% YoY), while the FY2025 annual figure was $338.2 million, down 7.71% from the prior year.
• Operating Income was $84.6 million for Q1 2026 at Chemed, down from $100.7 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $113.9 million in Q4 2024 to a low of -$192.9 million in Q4 2022.
• Historically, Operating Income has averaged $70.5 million across 5 years, with a median of $86.8 million in 2023.
• Biggest YoY gain for Operating Income was 157.74% in 2023; the steepest drop was 24.4% in 2023.
• A 5-year view of Operating Income shows it stood at -$192.9 million in 2022, then jumped by 157.74% to $111.4 million in 2023, then gained by 2.23% to $113.9 million in 2024, then dropped by 11.61% to $100.7 million in 2025, then slipped by 15.97% to $84.6 million in 2026.
• The last three Operating Income figures came in at $84.6 million (Q1 2026), $100.7 million (Q4 2025), and $74.8 million (Q3 2025), per Business Quant data.